Yifeng Bai

1.8k total citations · 1 hit paper
44 papers, 1.2k citations indexed

About

Yifeng Bai is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yifeng Bai has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 19 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Yifeng Bai's work include MicroRNA in disease regulation (9 papers), Lung Cancer Research Studies (9 papers) and Cancer-related molecular mechanisms research (8 papers). Yifeng Bai is often cited by papers focused on MicroRNA in disease regulation (9 papers), Lung Cancer Research Studies (9 papers) and Cancer-related molecular mechanisms research (8 papers). Yifeng Bai collaborates with scholars based in China and United States. Yifeng Bai's co-authors include Linlang Guo, Yanqin Sun, Ying Guo, Fa-Man Xiao, Hongzhan Liao, Fan Zhang, Yu Wang, Hongbo Guo, Tianzhu Liu and Yongguang Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Yifeng Bai

43 papers receiving 1.2k citations

Hit Papers

CTLs heterogeneity and plasticity: implications for cance... 2024 2026 2025 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CTLs heterogeneity and plasticity: implications for cancer immunotherapy
    2024 62 citations Anqi Lin, Aimin Jiang et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yifeng Bai China 18 819 631 275 143 96 44 1.2k
Hao Zhuang China 21 770 0.9× 460 0.7× 180 0.7× 118 0.8× 118 1.2× 60 1.1k
Huanhuan Joyce Chen United States 14 782 1.0× 425 0.7× 380 1.4× 130 0.9× 104 1.1× 22 1.3k
Yiwen Xia China 21 1.0k 1.3× 794 1.3× 146 0.5× 133 0.9× 127 1.3× 43 1.4k
Yuting Zhan China 19 739 0.9× 490 0.8× 234 0.9× 115 0.8× 183 1.9× 63 1.1k
Pit Ullmann Luxembourg 10 580 0.7× 452 0.7× 485 1.8× 144 1.0× 100 1.0× 10 1.1k
Gerrit Erdmann Germany 14 808 1.0× 323 0.5× 259 0.9× 136 1.0× 63 0.7× 25 1.1k
Chao Shang China 27 1.3k 1.6× 1.0k 1.6× 250 0.9× 231 1.6× 114 1.2× 80 1.9k
Ye Wu China 16 938 1.1× 482 0.8× 148 0.5× 134 0.9× 246 2.6× 37 1.2k
Bo Shen China 23 1.2k 1.5× 956 1.5× 314 1.1× 131 0.9× 189 2.0× 73 1.6k

Countries citing papers authored by Yifeng Bai

Since Specialization
Citations

This map shows the geographic impact of Yifeng Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Bai more than expected).

Fields of papers citing papers by Yifeng Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Bai. The network helps show where Yifeng Bai may publish in the future.

Co-authorship network of co-authors of Yifeng Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Bai. A scholar is included among the top collaborators of Yifeng Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Bai. Yifeng Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Shengkun, Hongyu Kuang, Anqi Lin, et al.. (2025). From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment. Journal of Translational Medicine. 23(1). 109–109. 1 indexed citations
2.
3.
4.
Lin, Anqi, Aimin Jiang, Cangang Zhang, et al.. (2024). CTLs heterogeneity and plasticity: implications for cancer immunotherapy. Molecular Cancer. 23(1). 58–58. 62 indexed citations breakdown →
5.
Bai, Yifeng, Zhirong Chen, Zhangjie Fu, et al.. (2023). CurveFormer: 3D Lane Detection by Curve Propagation with Curve Queries and Attention. 7062–7068. 34 indexed citations
6.
Gao, Zhifei, Yifeng Bai, Anqi Lin, et al.. (2023). Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment. Molecular Cancer. 22(1). 31–31. 90 indexed citations
7.
Wang, Yuntao, Yi Liu, Xiaohua Li, et al.. (2022). TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC. Frontiers in Pharmacology. 13. 875149–875149. 3 indexed citations
8.
He, Xiaojuan, et al.. (2022). Identification and validation of novel biomarkers affecting bladder cancer immunotherapy via machine learning and its association with M2 macrophages. Frontiers in Immunology. 13. 1051063–1051063. 11 indexed citations
9.
Li, Xiaohua, Yuntao Wang, Xuebing Li, et al.. (2021). The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC. Frontiers in Immunology. 12. 638763–638763. 36 indexed citations
10.
Zhou, Xiaogang, Jing Xiang, Yuntao Wang, et al.. (2021). Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy. Frontiers in Immunology. 12. 665002–665002. 2 indexed citations
11.
12.
Wang, Hongqiang, Yan Guo, Lin Shui, et al.. (2019). HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway. Journal of Experimental & Clinical Cancer Research. 38(1). 324–324. 31 indexed citations
13.
Bai, Yifeng, et al.. (2017). Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Biological Research. 50(1). 32–32. 37 indexed citations
14.
Yang, Lan, Honglin Hu, Ying Deng, & Yifeng Bai. (2014). [Role of SPHK1 regulates multi-drug resistance of small cell lung cancer 
and its clinical significance].. SHILAP Revista de lepidopterología. 17(11). 769–77. 7 indexed citations
15.
Xiao, Fa-Man, Yifeng Bai, Zhenzhu Chen, et al.. (2014). Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. European Journal of Cancer. 50(8). 1541–1554. 100 indexed citations
16.
Liu, Tianzhu, Xin Wang, Yifeng Bai, et al.. (2014). The HIF-2alpha dependent induction of PAP and adenosine synthesis regulates glioblastoma stem cell function through the A2B adenosine receptor. The International Journal of Biochemistry & Cell Biology. 49. 8–16. 36 indexed citations
17.
Liu, Huanxin, Juan Peng, Yifeng Bai, & Linlang Guo. (2013). [Up-regulation of DLL1 may promote the chemotherapeutic sensitivity in small cell lung cancer].. SHILAP Revista de lepidopterología. 16(6). 282–8. 4 indexed citations
18.
Bai, Yifeng, Hongzhan Liao, Tianzhu Liu, et al.. (2012). MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-à-go-go (EAG1). European Journal of Cancer. 49(3). 710–724. 79 indexed citations
19.
Guo, Linlang, Yongguang Liu, Yifeng Bai, et al.. (2010). Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. European Journal of Cancer. 46(9). 1692–1702. 125 indexed citations
20.
Sun, Yanqin, Yifeng Bai, Fan Zhang, et al.. (2009). miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochemical and Biophysical Research Communications. 391(3). 1483–1489. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Zhuang Breakdown of academic impact, for papers by Huanhuan Joyce Chen Breakdown of academic impact, for papers by Yiwen Xia Breakdown of academic impact, for papers by Yuting Zhan Breakdown of academic impact, for papers by Pit Ullmann Breakdown of academic impact, for papers by Gerrit Erdmann Breakdown of academic impact, for papers by Chao Shang Breakdown of academic impact, for papers by Ye Wu Breakdown of academic impact, for papers by Bo Shen
Rankless by CCL
2026